华纳药厂：2025年净利润同比增46.95%至2.41亿元，公司多项产品销售收入增长

Core Viewpoint - Warner Pharmaceuticals reported a revenue of 1.516 billion yuan for the year 2025, marking a year-on-year growth of 7.26% and a net profit attributable to the parent company of 241 million yuan, which represents a significant increase of 46.95% [1] Revenue Growth - The increase in total revenue is attributed to the growth in sales of formulation products, active pharmaceutical ingredients, intermediates, and technical service income [1] Net Profit Analysis - The rise in net profit attributable to the parent company is primarily influenced by investment income [1] - However, the net profit excluding non-recurring gains and losses decreased due to the accrual of stock incentive expenses; after adjusting for these expenses, the net profit attributable to the parent company was 182 million yuan, reflecting a year-on-year increase of 31.57% [1]